Search

Your search keyword '"Yumin Zhao"' showing total 241 results

Search Constraints

Start Over You searched for: Author "Yumin Zhao" Remove constraint Author: "Yumin Zhao"
241 results on '"Yumin Zhao"'

Search Results

1. Transcriptomic Analysis Reveals the Molecular Defense Mechanisms of Poa pratensis Against Powdery Mildew Fungus Blumeria graminis f. sp. Poae

2. A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

3. Petrositis caused by fluconazole-resistant candida: case report and literature review

4. Seismic Attenuation Extraction From Traffic Signals Recorded by a Single Seismic Station

5. Application of polymerized porcine hemoglobin in the ex vivo normothermic machine perfusion of rat livers

6. Investigating Linkages Between Spatiotemporal Patterns of the COVID-19 Delta Variant and Public Health Interventions in Southeast Asia: Prospective Space-Time Scan Statistical Analysis Method

7. Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma

8. The Requirements Analysis of Satellite Application in Marine Transportation Industry

9. Effects of puerarin on the Akt signaling pathway in bovine preadipocyte differentiation

10. Quantifying Urban Activities Using Nodal Seismometers in a Heterogeneous Urban Space

11. The Anti-Colon Cancer Effects of Essential Oil of Curcuma phaeocaulis Through Tumour Vessel Normalisation

12. Comparative Genome-Wide Alternative Splicing Analysis of Longissimus Dorsi Muscles Between Japanese Black (Wagyu) and Chinese Red Steppes Cattle

13. Inhibition of Fibroblast Activation in Uterine Leiomyoma by Components of Rhizoma Curcumae and Rhizoma Sparganii

14. Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer

15. Whole Genome Scan and Selection Signatures for Climate Adaption in Yanbian Cattle

16. Genome-wide assessment of genetic diversity and population structure insights into admixture and introgression in Chinese indigenous cattle

17. Comprehensive Analysis of miRNAs and Target mRNAs between Immature and Mature Testis Tissue in Chinese Red Steppes Cattle

18. Long-term retrospective assessment of a transmission hotspot for human alveolar echinococcosis in mid-west China.

19. Mechanism of Fibrosis Induced by Echinococcus spp.

20. A Missense Mutation of the HSPB7 Gene Associated with Heat Tolerance in Chinese Indicine Cattle

21. Detection of Bovine TMEM95 p.Cys161X Mutation in 13 Chinese Indigenous Cattle Breeds

22. Inhibitory Effect of Ionizing Radiation on Echinococcus granulosus Hydatid Cyst

23. The MAPK Signaling Pathways as a Novel Way in Regulation and Treatment of Parasitic Diseases

24. Community surveys and risk factor analysis of human alveolar and cystic echinococcosis in Ningxia Hui autonomous region, China

25. Impact of mental health visits on healthcare cost in patients with diabetes and comorbid mental health disorders.

26. Suppression of E. multilocularis hydatid cysts after ionizing radiation exposure.

29. Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study

31. Supplementary Table S2 from Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors

32. Supplementary Figure S4 from Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors

33. Supplementary Methods from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

34. Data from Safety and Antitumor Activity of α-PD-L1 Antibody as Monotherapy or in Combination with α-TIM-3 Antibody in Patients with Microsatellite Instability–High/Mismatch Repair–Deficient Tumors

35. Supplemental Figure 3 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

36. Data from Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes

37. Supplemental Figure 1 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

38. Supplemental Figure 4 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

39. Supplemental Figure 5 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

40. Supplemental Table 1 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

41. Supplemental Figure 2 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

42. Supplemental Table 2 from Safety and Clinical Activity of a New Anti-PD-L1 Antibody as Monotherapy or Combined with Targeted Therapy in Advanced Solid Tumors: The PACT Phase Ia/Ib Trial

43. Supplementary Tables and Figures from Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes

Catalog

Books, media, physical & digital resources